Related references
Note: Only part of the references are listed.Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format
R. Norman et al.
QUALITY OF LIFE RESEARCH (2016)
Testing the measurement invariance of the EORTC QLQ-C30 across primary cancer sites using multi-group confirmatory factor analysis
D. S. J. Costa et al.
QUALITY OF LIFE RESEARCH (2015)
AN AUSTRALIAN DISCRETE CHOICE EXPERIMENT TO VALUE EQ-5D HEALTH STATES
Rosalie Viney et al.
HEALTH ECONOMICS (2014)
Valuing SF-6D Health States Using a Discrete Choice Experiment
Richard Norman et al.
MEDICAL DECISION MAKING (2014)
Should Linking Replace Regression When Mapping from Profile-Based Measures to Preference-Based Measures?
Peter M. Fayers et al.
VALUE IN HEALTH (2014)
Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approach
Daniel S. J. Costa et al.
PATIENT-RELATED OUTCOME MEASURES (2014)
Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial
N. C. Tebbutt et al.
BRITISH JOURNAL OF CANCER (2013)
The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study
Allan 'Ben' Smith et al.
PSYCHO-ONCOLOGY (2013)
Mapping utilities from cancer-specific health-related quality of life instruments: a review of the literature
Helen McTaggart-Cowan et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2013)
Meta-Analysis of Cognitive Functioning in Breast Cancer Survivors Previously Treated With Standard-Dose Chemotherapy
Heather S. L. Jim et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
A Meta-analysis of Chemotherapy related Cognitive Impairment in Patients with Breast Cancer
Jin-Hee Park et al.
JOURNAL OF KOREAN ACADEMY OF NURSING (2012)
The EORTC quality of life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanish patients
Juan Ignacio Arraras et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis
Stephen J. Clarke et al.
EUROPEAN JOURNAL OF CANCER (2011)
The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severities
Paulos Teckle et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2011)
The Use of Rasch Analysis in Reducing a Large Condition-Specific Instrument for Preference Valuation: The Case of Moving from AQLQ to AQL-5D
Tracey A. Young et al.
MEDICAL DECISION MAKING (2011)
Time Trade-Off Derived EQ-5D Weights for Australia
Rosalie Viney et al.
VALUE IN HEALTH (2011)
Deriving a Preference-Based Measure for Cancer Using the EORTC QLQ-C30
Donna Rowen et al.
VALUE IN HEALTH (2011)
Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial
N. C. Tebbutt et al.
BRITISH JOURNAL OF CANCER (2010)
Meeting the Information Needs of a National Drug Payer: Aspirations of the Guidelines from Australia
Andrew S. Mitchell et al.
DRUG DEVELOPMENT RESEARCH (2010)
A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures
John E. Brazier et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2010)
Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer
R. N. Whistance et al.
EUROPEAN JOURNAL OF CANCER (2009)
VALIDATION OF THE EORTC QLQ-C30 AND EORTC QLQ-H&N35 IN PATIENTS WITH LARYNGEAL CANCER AFTER SURGERY
Susanne Singer et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2009)
The first stage of developing preference-based measures: constructing a health-state classification using Rasch analysis
Tracey Young et al.
QUALITY OF LIFE RESEARCH (2009)
A Patient-Based Utility Measure of Health for Clinical Trials of Cancer Therapy Based on the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire
A. Simon Pickard et al.
VALUE IN HEALTH (2009)
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
Dennis Revicki et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
The use of QALY weights for QALY calculations - A review of industry submissions requesting listing on the Australian pharmaceutical benefits scheme 2002-4
Paul A. Scuffham et al.
PHARMACOECONOMICS (2008)
Estimation of a preference-based index from a condition-specific measure: The King's Health Questionnaire
John Brazier et al.
MEDICAL DECISION MAKING (2008)
An introduction to the Rasch measurement model: An example using the Hospital Anxiety and Depression Scale (HADS)
Julie F. Pallant et al.
BRITISH JOURNAL OF CLINICAL PSYCHOLOGY (2007)
Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy X 1) versus multiple fractions (3 Gy X 10) in the treatment of painful bone metastases
Stein Kaasa et al.
RADIOTHERAPY AND ONCOLOGY (2006)
Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules
M Cengiz et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial
G Velikova et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Quality of life of breast cancer patients in Taiwan: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-BR23
WC Chie et al.
PSYCHO-ONCOLOGY (2003)
Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: A prospective survey in 300 adult cancer patients
P Klepstad et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2003)
A phase 2 study of bortezomib in relapsed, refractory myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The estimation of a preference-based measure of health from the SF-36
J Brazier et al.
JOURNAL OF HEALTH ECONOMICS (2002)
The 15D instrument of health-related quality of life: properties and applications
H Sintonen
ANNALS OF MEDICINE (2001)
A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients
K Bjordal et al.
EUROPEAN JOURNAL OF CANCER (2000)
Share Paper
